Mallory Thompson
Obstetrics & Gynecology · Live Oak, TXNPI 1669891982
Payments from drug & device makers
Across 89 payments — averaging $19.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$454
- Exeltis, USA Inc.$164
- Mayne Pharma Commercial LLC$160
- Sumitomo Pharma America, Inc.$114
- Organon$103
- Astellas Pharma US Inc$79
- plus $698 from 22 others
What the payments were for
- Food & beverage$1,773100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 20 | $454 |
| Exeltis, USA Inc. | 9 | $164 |
| Mayne Pharma Commercial LLC | 6 | $160 |
| Sumitomo Pharma America, Inc. | 6 | $114 |
| Organon | 6 | $103 |
| Astellas Pharma US Inc | 4 | $79 |
| Shield Therapeutics Inc | 3 | $69 |
| Myovant Sciences Inc. | 3 | $62 |
| Hologic Sales And Service, LLC | 3 | $57 |
| Avion Pharmaceuticals | 3 | $54 |
| Agile Therapeutics, Inc. | 3 | $49 |
| Biogen | 2 | $48 |
| Pfizer | 2 | $41 |
| Millicent US Inc | 2 | $40 |
| Mission Pharmacal Company | 1 | $36 |
| Therapeuticsmd, Inc. | 2 | $33 |
| Merck | 2 | $32 |
| Coopersurgical, Inc. | 1 | $25 |
| Medtronic | 1 | $25 |
| Covidien LP | 1 | $19 |
| Ascend Therapeutics US, LLC | 1 | $19 |
| Meditrina | 1 | $17 |
| Bayer | 1 | $16 |
| Acessa Health Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $15 |
| Mylan Pharmaceuticals Inc. | 1 | $15 |
| Lupin Inc. | 1 | $12 |
| Unified Women's Healthcare, LP | 2 | $0 |
How this compares
$1,773 in reported general payments places this provider in the 60th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 23 | $2,729 |
| Medroxyprogesterone Acetate | 22 | $119 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Live Oak
- Susan CrockettLive Oak$269K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.